drugset / Trial / NCT06523101

A Study of PJ009 in Healthy Adult Volunteers

NCT06523101 ↗

Phase 1 Completed 24 enrolled Chongqing Peg-Bio Biopharm Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The main aim of this clinical trial is to assess the safety of PJ009 in healthy adult volunteers aged 18-45. The main questions it aims to answer are: * Is PJ009 safe in healthy adult? Participants will * Receive single dose of PJ009 or placebo according to weight, and then multiple doses daily for 7 days, * Stay in hospital for assessment.

Timeline

Start
2023-02-28
Primary completion
2023-05-15
Completion
2023-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PJ009 Unknown — Subcutaneous

Indications